Abstract The World Health Organization has recommended that a Sabin inactivated polio
vaccine (IPV) should gradually and synchronously replace oral polio vaccines for routine …

Antibody responses of Macaca fascicularis against a new tetravalent vaccine composed of
diphtheria toxoid, tetanus toxoid, acellular pertussis antigens, and inactivated poliovirus …

Background: With the goal of global eradication of poliomyelitis due to wild-type viruses
within sight, WHO now recommends that infants receive at least one dose of trivalent …

GMP-batches of Sabin-IPV were characterized for their antigenic and immunogenic
properties. Antigenic fingerprints of Sabin-IPV reveal that the D-antigen unit is not a fixed …

Abstract Background. Phase II and III clinical studies were conducted to evaluate
immunogenicity and safety of a novel DTaP-IPV vaccine consisting of Sabin inactivated …

As one aspect of its campaign to eradicate poliomyelitis, the World Health Organization
(WHO) has encouraged development of the inactivated polio vaccine (IPV) derived from the …

Objective To evaluate the safety of concomitantly administering inactivated poliomyelitis
vaccine produced from Sabin strains (sIPVs) with other vaccines. Methods A descriptive …

This phase Ⅱ, randomized, controlled trial aimed to evaluate the safety and immunogenicity
of a various Sabin IPV preparations. Six hundred infants aged 60~ 90 days received one of …

Inactivated polio vaccine (IPV) was prepared with the Sabin strains, normally used for the
attenuated live vaccine. The vaccine was characterized with respect to its antigenicity as …

A collaborative study was conducted with an aim to establish the 3 rd International Standard
(IS) for inactivated polio vaccine (IPV). Three candidate samples provided by three different …